Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Positive results from initial lopinavir-ritonavir COVID-19 clinical trial

europeanpharmaceuticalreviewApril 08, 2020

Tag: lopinavir-ritonavir , COVID-19 , clinical trial , Recovery

PharmaSources Customer Service